Drugs and Health Alliance

The Drugs and Health Alliance (DHA) is a group of organisations and individuals who support an evidence-based, public health-led approach to dealing with illegal drugs.

Press releases

Press release May 2007

Tel: 0117 941 5810 or 07970 174747
Web: www.drugshealthalliance.net

Our criminal justice approach to drugs has failed. The priority is public health, says new alliance of drug charities...

A new Alliance of drug charities launches today in London, calling on the Government to put public health, harm reduction and tackling poverty and exclusion at the heart of UK drug policy.

The Drugs and Health Alliance (DHA) is a group of organisations and individuals who support an evidence-based, public health-led approach to dealing with illegal drugs. An overwhelming body of evidence shows that the criminal justice-led approach to illicit drugs at home and abroad increases harms associated with their production, supply and use , whilst public health-led approaches consistently reduce harm. For many years there has been reluctance from the voluntary sector to criticise policy, because of their reliance on government funding; problems that are perpetuated by the Government’s failure to conduct an evidence-based review of the progress of the UK drug strategy and its failure to consult with informed public opinion.

In 2007, the UK ten-year drug strategy comes to an end and a window of opportunity opens. DHA supporters want to be included in the policy development process to assist in putting in place an effective strategy for the next decade.

Where:

Adelphi Room
Royal Society of Arts (RSA)
8 John Adam Street
London WC2N 6EZ

When:

Thursday 3 May, 11:00 am

Danny Kushlick (Director, Transform Drug Policy Foundation) spokesperson for DHA said:

“Ten years ago the Government brought in an ex police officer (Keith Hellawell) as drug czar, to head up the UK drug strategy. A decade down the line, the evidence of the failure of our enforcement-led approach is all too apparent. In no other area of policy-making would we dream of criminalising recreation on the one hand and disadvantage and distress on the other. DHA is calling for the upcoming drug strategy to reallocate resources away from enforcement and towards a public health approach to drugs. It is truly criminal that the Government has not seen fit to publicly audit the enforcement approach to drugs and compare it with health interventions.”

Professor Gerry Stimson (Executive Director of IHRA) said:

“This government's first war was a war on drugs – one that rumbles on with a growing role call of casualties. The mistake was to move responsibility for drugs policy to the Home Office rather than the appropriate health agency, and to downgrade health targets whilst focusing almost exclusively on crime reduction. It's time to refocus drugs policy, and get back to dealing with the evidence of what works at reducing harm for users and the wider community.”

David Liddell (Scottish Drugs Forum) said:

“The UK has one of the highest drug problems per head of population in Europe.  It’s therefore crucially important that any new strategy recognises the causal factors of poverty and exclusion as an integral aspect that we must address if we are to make a substantial impact on the problem in the years ahead.”

Martin Blakeborough (Director Kaleidoscope Project and member of the Advisory Council on Drug Misuse) said:

“Kaleidoscope believes the health of drug users must be the priority and therefore welcomes the launch of DHA. It is clear that in the past ten years the priority has been community safety at the expense of the basic health care and human rights of illicit drug users. The upcoming review of UK strategy provides the opportunity to change this.”

Sebastian Saville (Executive Director Release) said:

“It is becoming increasingly apparent that more and more mainstream groups now readily accept that many of the harms associated with illicit drug use are in fact caused or exacerbated by the present legal system, rather than the drugs themselves. The ‘crime reduction agenda’ has meant that civil liberties and public health have increasingly taken a back seat in drug policy. It is time for a change.”

Daren Garratt (The Alliance) said:

“The Alliance is proud to be a partner, supporter and contributing member of the Drugs and Health Alliance. The Government's 10-Year Drug Strategy and its continued focus on the target-driven criminalisation of drug use and drug users, has only proved to increase the harm, stigma and alienation experienced by one of the most marginalised sectors of our communities. We welcome the work of the DHA and call for a pragmatic, non-discriminatory, evidence based drug policy that reestablishes the holistic health and social needs of the individual drug user as its core objective.”

Paul Crawford Walker (Socialist Health Association) said:

“As a public health practitioner the launch of DHA is very welcome as the public health community has long realised that the only sensible approach to drug misuse policy is one which involves a public health perspective and framework rather than a repressive criminal justice one. I am confident that the Alliance will make a real difference to how drug misuse is regarded and dealt with in this country.”

Debra Lapthorne (Director of Public Health, Plymouth) said:

“Plymouth Public Health Development Unit is pleased to be contributing to the DHA. We welcome the inclusive approach the DHA represents and look forward to a time when some of the most marginalised and stigmatized groups in our communities can enjoy sustainable well being. The Public Health approach which the DHA embodies gives a real opportunity to deliver drug policy based on sound evidence rather than fear and prejudice.”

Neil Hunt (UK Harm Reduction Alliance) said:

“The 10 year strategy has brought important improvements but leaves much undone. For a supposedly 'evidence-based' drug strategy we have a dearth of evidence. There is an urgent need to examine and evaluate more progressive approaches to preventing drug problems that move beyond the current, crude enforcement approach. At the same time, we need to strengthen and refine the assorted harm reduction-based treatment approaches that have been shown to work.”

Contacts:

Press contact: Danny Kushlick 07970 174747
Website: www.drugshealthalliance.net

Notes

Members:

Individuals:

Consensus Statement

Read the full consensus statement on the home page.

End